Drug cos forging data for approval, mislabelling brands to be barred

In a bold move to combat deception in the pharmaceutical industry, the government is instituting strict penalties for drugmakers caught submitting forged or misleading documents during the approval process. This initiative is a direct response to the tragic incidents of child fatalities linked to tainted cough syrups.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4ltOwLk
via IFTTT